Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

953 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Kline J, Subbiah S, Lazarus HM, van Besien K. Kline J, et al. Bone Marrow Transplant. 2008 Mar;41(6):505-13. doi: 10.1038/sj.bmt.1705931. Epub 2007 Nov 19. Bone Marrow Transplant. 2008. PMID: 18026144 Review.
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
Kebriaei P, Kline J, Stock W, Kasza K, Le Beau MM, Larson RA, van Besien K. Kebriaei P, et al. Among authors: kline j. Bone Marrow Transplant. 2005 May;35(10):965-70. doi: 10.1038/sj.bmt.1704938. Bone Marrow Transplant. 2005. PMID: 15806131
Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Kline JP, Larson RA. Kline JP, et al. Expert Opin Pharmacother. 2005 Dec;6(15):2711-8. doi: 10.1517/14656566.6.15.2711. Expert Opin Pharmacother. 2005. PMID: 16316309 Review.
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Kline J, Pollyea DA, Stock W, Artz A, Rich E, Godley L, Zimmerman T, Thompson K, Pursell K, Larson RA, van Besien K. Kline J, et al. Bone Marrow Transplant. 2006 Feb;37(3):307-10. doi: 10.1038/sj.bmt.1705249. Bone Marrow Transplant. 2006. PMID: 16400339 Clinical Trial.
Severe intestinal graft-versus-host disease following autologous stem cell transplantation.
Kline J, van Besien K, Nathanson J, Noffsinger A, Artz A. Kline J, et al. Bone Marrow Transplant. 2006 Sep;38(5):391-2. doi: 10.1038/sj.bmt.1705460. Bone Marrow Transplant. 2006. PMID: 16915228 No abstract available.
Nelarabine in the treatment of refractory T-cell malignant diseases.
Kline J, Larson RA. Kline J, et al. Expert Opin Pharmacother. 2006 Sep;7(13):1791-9. doi: 10.1517/14656566.7.13.1791. Expert Opin Pharmacother. 2006. PMID: 16925505 Review.
Immune resistance orchestrated by the tumor microenvironment.
Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. Gajewski TF, et al. Among authors: kline j. Immunol Rev. 2006 Oct;213:131-45. doi: 10.1111/j.1600-065X.2006.00442.x. Immunol Rev. 2006. PMID: 16972901 Review.
Chimerism does not predict for outcome after alemtuzumab based conditioning.
Michaelis L, Lin S, Joseph L, Artz AS, Kline J, Pollyea D, Stock W, Rich E, Collins-Jones D, Casey B, Del Cerro P, van Besien K. Michaelis L, et al. Among authors: kline j. Bone Marrow Transplant. 2007 Jul;40(2):181. doi: 10.1038/sj.bmt.1705707. Epub 2007 May 14. Bone Marrow Transplant. 2007. PMID: 17502895 No abstract available.
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
Poiré X, Artz A, Larson RA, Kline J, Odenike O, Rich E, Godley L, Stock W, van Besien K. Poiré X, et al. Among authors: kline j. Leuk Lymphoma. 2009 Jan;50(1):85-91. doi: 10.1080/10428190802626624. Leuk Lymphoma. 2009. PMID: 19142796 Free PMC article.
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model.
Zhang L, Gajewski TF, Kline J. Zhang L, et al. Among authors: kline j. Blood. 2009 Aug 20;114(8):1545-52. doi: 10.1182/blood-2009-03-206672. Epub 2009 May 5. Blood. 2009. PMID: 19417208 Free PMC article.
953 results
Jump to page